For research use only. Not for therapeutic Use.
Bay 55-9837 is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 may be a useful therapy for the research of type 2 diabetes[1].
Catalog Number | P000186 |
CAS Number | 463930-25-8 |
Molecular Formula | C148H239ClN44O42 |
Purity | ≥95% |
Reference | [1]. Tsutsumi M, et, al. A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes. Diabetes. 2002 May; 51(5): 1453-60. |